34 Results

People

  1. Prockop
    Prockop
  2. Kernan
    Kernan
  3. O'Reilly
    O'Reilly
  4. Boulad
    Boulad
  5. Hsu
    Hsu
  6. Young
    Young
  7. Perales
    Perales
  8. Castro-Malaspina
    Castro-Malaspina
  9. Jakubowski
    Jakubowski
  10. Papadopoulos
    Papadopoulos

Groups

  1. Center for Hematologic Malignancies (34)
  2. Department of Medicine (34)
  3. GSK Faculty (34)
  4. Hematologic Malignancies Research (34)
  5. Pediatrics, Department of (34)
  6. Sloan Kettering Institute Faculty (34)
  7. Stem Cell Transplantation and Cellular Therapy Service (34)
  8. Hematologic Malignancies, Division of (33)
  9. Tow Center for Developmental Oncology (TCDO) (29)
  10. Immunology Program Faculty (28)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Pediatrics, Department of"
  4. "Susan Prockop"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (12)
  3. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (34)
  2. Department of Medicine (34)
  3. GSK Faculty (34)
  4. Hematologic Malignancies Research (34)
  5. Pediatrics, Department of (34)
  6. Sloan Kettering Institute Faculty (34)

More Groups

People
  1. Susan Prockop (34)
  2. Farid Boulad (31)
  3. Nancy Kernan (27)
  4. Richard O'Reilly (27)
  5. Katharine Hsu (20)
  6. James Young (19)

More People

Years
  1. 2022 (2)
  2. 2020 (4)
  3. 2019 (3)
  4. 2017 (2)
  5. 2016 (1)
  6. 2015 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (13)
  2. Blood (13)
  3. Bone Marrow Transplantation (3)
  4. Annals of the New York Academy of Sciences (1)
  5. Blood Advances (1)
  6. Journal of Clinical Investigation (1)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. Elsevier Inc. (13)
  3. Nature Publishing Group (5)
  4. American Society for Clinical Investigation (1)
  5. John Wiley & Sons (1)

Results (34)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
    Journal Article

    Hasan, A. N.; Doubrovina, E.; Sottile, R.; Prockop, S.; Klatt, M. G.; Heller, G.; Selvakumar, A.; Barnett, L.; Hsu, K. C.; O’Reilly, R. J.
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: A phase 1 trial
    Journal Article

    Boulad, F.; Maggio, A.; Wang, X.; Moi, P.; Acuto, S.; Kogel, F.; Takpradit, C.; Prockop, S.; Mansilla-Soto, J.; Cabriolu, A.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant
    Journal Article

    Fabrizio, V. A.; Kernan, N. A.; Boulad, F.; Cancio, M.; Allen, J.; Higman, M.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save